A Single-tube Assay for Detecting ALK, ROS1 and RET Fusions in Lung Cancer
Maruja Lira, Pfizer Inc, speaking at Point-of-Care Diagnostics World Congress 2013.
Date Posted: Thursday, November 14, 2013
No Business Split for Pfizer Pfizer decides remaining one company best positions company to maximize future value creation. Tuesday, September 27, 2016Pfizer to Acquire AstraZeneca Antibiotics Pfizer has announced that it has entered an agreement with AstraZeneca to acquire its late-stage small molecule business for up to $1.575 billion. Wednesday, August 24, 2016Pfizer's $14Bn Acquisition of Medivation It has been announced that Pfizer will acquire Medivation for $81.50 a share for a total value of roughly $14 billion. Tuesday, August 23, 2016